Etymologia: Carbapenem

Etymologia: Carbapenem

Bibliographic Details
Main Author:	Ronnie Henry
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2019-07-01
Series:	Emerging Infectious Diseases
Subjects:	carbapenem antibiotics antimicrobial dugs broad-spectrum β-lactam antibiotics thienamycin imipenem
Online Access:	https://wwwnc.cdc.gov/eid/article/25/7/et-2507_article

Similar Items

Mechanisms of Action of Carbapenem Resistance
by: Caterina Aurilio, et al.
Published: (2022-03-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non-Burn Patients in Tehran
by: Zahra Ghareboghy Sarmad, et al.
Published: (2015-09-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non Burn Patients in Tehran
by: Zahra Ghareboghy-Sarmad, et al.
Published: (2015-11-01)

METALLO-ß-LACTAMASE PRODUCTION IN IMIPENEM RESISTANT STRAINS OF PSEUDOMONAS AERUGINOSA
by: Fazle Bari, et al.
Published: (2019-06-01)

Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
by: Yanfang Feng, et al.
Published: (2021-11-01)

Carbapenems versus β-lactam and β-lactamase inhibitors for treatment of nosocomial pneumonia: A systematic review and meta-analysis
by: Huai Qin Cang, et al.
Published: (2023-10-01)

The Carbapenems Issue
by: David Sotello, et al.
Published: (2018-07-01)

Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant Enterobacterales Isolates
by: Jocelyn Qi-Min Teo, et al.
Published: (2023-06-01)

Carbapenem-Resistant Klebsiella pneumoniae Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report
by: Ji Z, et al.
Published: (2021-08-01)

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
by: Davide Carcione, et al.
Published: (2021-08-01)

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
by: Richard eWatkins, et al.
Published: (2013-12-01)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
by: Mario López-Pérez, et al.
Published: (2021-12-01)

Pharmacokinetic optimisation of beta-lactams for the treatment of ventilator-associated pneumonia
by: G. L. Drusano
Published: (2007-08-01)

Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in Penicillin Allergic Patients
by: Christina Caplinger, et al.
Published: (2016-01-01)

Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
by: J. Rello
Published: (2007-08-01)

Detection of β-lactamase, blaZ and mecA in penicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Garanhuns, Brazil
by: Amanda Pereira Lucas, et al.
Published: (2021-07-01)

Health risks associated with the presence of antibiotic resistant bacteria in greywater
by: Juan Moretton, et al.
Published: (2012-04-01)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Lei Zhang, et al.
Published: (2023-06-01)

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Frontiers Production Office
Published: (2024-01-01)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

Supporting Correct Antimicrobial Choices in Sepsis
by: Balwinder Bolla, et al.
Published: (2023-03-01)

Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
by: Brendan Mackay, et al.
Published: (2022-10-01)

Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates
by: Mona I. Shaaban, et al.
Published: (2017-04-01)

Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
by: Nada A Alsaleh, et al.
Published: (2020-11-01)

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination
by: Alla V. Filimonova, et al.
Published: (2021-12-01)

Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
by: Buthaina Jubeh, et al.
Published: (2020-06-01)

Characterization of the antibacterial activity from ethanolic extracts of the botanical, Larrea tridentata
by: Tiffany Turner, et al.
Published: (2021-06-01)

Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients
by: A.A. Adegoke, et al.
Published: (2022-07-01)

The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition
by: Jonathan Turner, et al.
Published: (2022-03-01)

Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
by: Miranda J. Wallace, et al.
Published: (2022-02-01)

Quantitative Determination of Unbound Piperacillin and Imipenem in Biological Material from Critically Ill Using Thin-Film Microextraction-Liquid Chromatography-Mass Spectrometry
by: Robert Włodarski, et al.
Published: (2022-01-01)

<i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio
by: Maria V. Golikova, et al.
Published: (2022-06-01)

Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study
by: Erwann Cariou, et al.
Published: (2023-03-01)

Assessment of well water as a reservoir for extended-spectrum β-lactamases (ESBL) and carbapenem resistant Enterobacteriaceae from Iwo, Osun state, Nigeria
by: Omowumi Temitayo Akinola, et al.
Published: (2022-06-01)

Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action
by: Khalid M. Dousa, et al.
Published: (2022-02-01)

The functional convergence of antibiotic resistance in β‐lactamases is not conferred by a simple convergent substitution of amino acid
by: Vivek Keshri, et al.
Published: (2019-10-01)

Overview and Insights into Carbapenem Allergy
by: Yuman Lee, et al.
Published: (2019-08-01)

Comparative Evaluation of the Antibacterial Efficacy of two different Formulations of Calcium hydroxide as Intracanal Medicaments against Enterococcus faecalis: An In vitro study
by: Priya Sapra, et al.
Published: (2017-11-01)

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
by: Fred C. Tenover, et al.
Published: (2006-08-01)

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
by: Xuebin Tian, et al.
Published: (2020-07-01)